Sign up to see all 5.
None.
No insider has filed a notice of proposed sale (Form 144) for Avalyn Pharma Inc in the last 12 months.
There are not yet two fiscal years of reported share counts for Avalyn Pharma Inc.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
F
FMR LLC
|
5.8M | 13.16% | NEW | Q2 '26 | 0.0% | |
|
Shares held by quarter
Peak holding5.8M (Q2'26)
Change over 8 quarters+5.8M
Share of the company13.160%
|
||||||
|
NH
Novo Holdings A/s
|
3.9M | 8.76% | NEW | Q2 '26 | 7.4% | |
|
Shares held by quarter
Peak holding3.9M (Q2'26)
Change over 8 quarters+3.9M
Share of the company8.760%
|
||||||
23 more super investors behind a free account
See every manager holding Avalyn Pharma Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FS
Fidelity Securities Fund
|
$35.5M | 1.2M | 2.78% | 0.40% | July 31, 2026 |
|
FS
Fidelity Securities Fund
|
$18.1M | 627.2K | 1.41% | 0.39% | July 31, 2026 |
23 more funds behind a free account
See every fund holding Avalyn Pharma Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
SO
SR One Capital Management, LLC
5%+ holder
13D · 7.5%
|
3.3M | 7.46% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
AC
Aaron Cowen
5%+ holder
13D · 5.6%
|
2.5M | 5.65% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
4 more holders behind a free account
See every insider and 5%+ holder of Avalyn Pharma Inc.
Sign up freeLoading...